Gross Margin (Quarterly)

Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues

Pfizer Inc. (PFE) had Gross Margin of 74.95% for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$16.65B
Net Income	$3.54B
Cost of Goods Sold	$4.17B
Gross Profit	$12.48B
Operating Expenses	$12.80B
Operating Income	$3.85B
Non-Operating Income/Expense	$-517.00M
Pre-Tax Income	$3.33B
Normalized Pre-Tax Income	$3.33B
Income after Taxes	$3.55B
Income from Continuous Operations	$3.55B
Consolidated Net Income/Loss	$3.55B
Normalized Income after Taxes	$3.55B
EBIT	$3.85B
EBITDA	$5.51B
Weighted-Average Shares Outstanding (Basic)	5.68B
Weighted-Average Shares Outstanding (Diluted)	5.71B
Earnings per Share (EPS) (Basic)	$0.62
Earnings per Share (EPS) (Diluted)	$0.62
Balance Sheet Financials
Current Assets	$46.92B
Property, Plant, and Equipment	$18.88B
Long-Term Assets	$161.81B
Total Assets	$208.73B
Current Liabilities	$36.60B
Long-Term Debt	$57.41B
Long-Term Liabilities	$79.04B
Total Liabilities	$115.64B
Common Equity	$93.10B
Tangible Shareholders Equity	$-27.33B
Shareholders Equity	$93.10B
Common Shares Outstanding	5.69B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.36B
Cash Flow from Investing Activities	$4.79B
Cash Flow from Financial Activities	$-10.90B
Beginning Cash	$1.11B
End Cash	$1.39B
Increase/Decrease in Cash	$287.00M
Stock-Based Compensation	$574.00M
Common Stock Dividends Paid	$-7.33B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.28
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.38
Debt to Equity Ratio	0.66
Gross Margin	74.95%
Operating Margin	23.12%
EBIT Margin	23.12%
EBITDA Margin	--
Pre-Tax Profit Margin	20.02%
Profit Margin	21.26%
Free Cash Flow	$4.57B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.08
Inventory Turnover	0.36
Receiveable Turnover	1.17
Days Sales in Receivables	77.06
Return on Equity	3.81%
Return on Tangible Equity	-12.99%
Return on Assets	1.70%
Return on Investments	2.36%
Book Value Per Share	$16.37
Free Cash Flow per Share	$0.80
Operating Cash Flow per Share	$1.11

Data from Zacks Investment Research, Inc.